Groowe Groowe / Newsroom / PHAT
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

PHAT News

Phathom Pharmaceuticals, Inc. Common Stock

Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting

globenewswire.com
PHAT

Form 8-K

sec.gov
PHAT

Phathom Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update

globenewswire.com
PHAT

Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026

globenewswire.com
PHAT

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

globenewswire.com
PHAT

Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising Incidence and Advancements in Targeted Therapies | DelveInsight

prnewswire.com
AMGN MRK ZLAB PHAT

H. pylori Infections Market in the 6MM to Observe Stupendous Growth at a CAGR of 9.5% During the Forecast Period (2026-2036) | DelveInsight

prnewswire.com
RDHL CPIX PHAT

Form 8-K

sec.gov
PHAT

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance

globenewswire.com
PHAT

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

globenewswire.com
PHAT